Aquestive Therapeutics, Inc. AQST Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s current debt?
- Aquestive Therapeutics, Inc. (AQST) reported current debt of $14.54M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s current debt changed year-over-year?
- Aquestive Therapeutics, Inc.'s current debt increased by 52.4% year-over-year, from $9.54M to $14.54M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.